Alexey Schulga

20PUBLICATIONS
40CO-AUTHORS
Predictive and prognostic markersProteins and peptidesCancer therapy (excl. chemotherapy and radiation therapy)Medical devicesGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Nov 13, 2025
Comparative Preclinical Evaluation of the Tumor-Targeting Properties of Radioiodine and Technetium-Labeled Designed Ankyrin Repeat Proteins for Imaging of Epidermal Growth Factor Receptor Expression in Malignant Tumors.

Mariia Larkina, Gleb Yanovich, Lutfi Aditya Hasnowo

|Jun 13, 2025
Targeting of Epithelial Cell Adhesion Molecule-Expressing Malignant Tumors Using an Albumin-Binding Domain-Fused Designed Ankyrin Repeat Protein: Effect of the Molecular Architecture.

Vladimir Tolmachev, Anzhelika Vorobyeva, Alia Hani Binti Rosly

|Nov 09, 2024
Structural Basis of Activity of HER2-Targeting Construct Composed of DARPin G3 and Albumin-Binding Domains.

Anastasia G Konshina, Eduard V Bocharov, Elena V Konovalova

|Aug 29, 2024
Phase I Clinical Evaluation of Designed Ankyrin Repeat Protein [99mTc]Tc(CO)3-(HE)3-Ec1 for Visualization of EpCAM-Expressing Lung Cancer.

Roman Zelchan, Vladimir Chernov, Anna Medvedeva

|Apr 27, 2024
Preclinical Evaluation of HER2-Targeting DARPin G3: Impact of Albumin-Binding Domain (ABD) Fusion.

Sergey M Deyev, Maryam Oroujeni, Javad Garousi

|Feb 23, 2024
Targeted Delivery of HSP70 to Tumor Cells via Supramolecular Complex Based on HER2-Specific DARPin9_29 and the Barnase:Barstar Pair.

Ludmila G Alekseeva, Olga V Ovsyanikova, Alexey A Schulga

Pageof 4

Frequent Collaborators

14 joint publications

Vladimir Tolmachev

13 joint publications

Sergey M Deyev

10 joint publications

Anna Orlova

10 joint publications

Anzhelika Vorobyeva